RAPGEF3 and cardiovascular disorder: A study has shown that the activation of the EPAC/Rap1 signalling pathway has a neuroprotective effect on brain damage caused by cerebral ischaemia – reperfusion through the restoration of the blood – brain barrier, which provides a new perspective for the treatment of cardiovascular diseases [224].